SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SAFESKIN

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Madpinto who wrote (323)6/24/1998 1:13:00 AM
From: Beltropolis Boy  Read Replies (2) of 828
 
culled from the fool 'boreds' although i have yet to confirm it with the newswires. would explain today's jump in price and volume. fwiw.

-----
Date: 6/23/98 7:25:03 PM (ET)

NEW YORK -(Dow Jones)- Seidler Amdec Research on Tuesday raised its rating on Safeskin Corp. to "long-term buy" from "hold," according to analyst Laurie Goldstein.

In a research note, Goldstein said she also raised her earnings estimates for 1998 and 1999 to 96 cents a share and $1.24 a share from 90 cents a share and $1.18 a share, respectively.

Goldstein, who has a 12-month price target of $45 on the shares, said she raised her outlook on the company because of the company's potential capacity expansion and local currency rates in Malaysia and Thailand, which she believes will contribute to strong margins.

"With new capacity coming on, Safeskin is now poised to boost its top-line growth rate in the 30% and up range," the analyst said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext